Findings

What do systematic reviews say?

29 questions · 29 findings · 6 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 8 · 27.6%GRADE not reported 0 · 0%Very low 9 · 31%Low 10 · 34.5%Moderate 2 · 6.9%High 0 · 0%

Individually applied blue‐enriched light vs no treatment

Adverse events · daytime workers

The review found no eligible studies for this question.

1 finding from 1 review

Workplace lighting for improving alertness and mood in daytime workers 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Individually applied blue‐enriched light vs no treatment

Alertness · daytime workers

1 finding from 1 review

Workplace lighting for improving alertness and mood in daytime workers 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Very low

Individually applied blue‐enriched light vs no treatment

Mood · daytime workers

1 finding from 1 review

Workplace lighting for improving alertness and mood in daytime workers 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Very low

COE with light-based detection (e.g. ViziLite Plus, Microlux/DL, VELscope, Identafi 3000) vs COE with vital rinsing (toluidine blue/tolonium chloride)

Outcome not reported · Apparently healthy adults not reporting symptoms of OPMD or OSCC, attending an organised screening or surveillance programme, or screened…

The review found no eligible studies for this question.

1 finding from 1 review

Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy… 2021 · Cochrane All outcomes
No eligible studies; planned comparative analysis (COE with vital rinse vs COE with light-based detection) not populated in this version.
0 studies
No studies found

ALA‐PDT vs blue light only

Participant's global assessment of improvement Non‐standardised scale5 · Moderate and severe acne vulgaris

ALA‐PDT showed no clear difference in participant's global assessment of improvement Non‐standardised scale5 compared with blue light only (low certainty).

1 finding from 1 review

Light therapies for acne 2016 · Cochrane Headline outcomes only
RR 0.87 [0.72, 1.04]
1 study · 266 participants
Low

ALA‐PDT vs blue light only

Investigator‐assessed change in inflamed lesions (ILs) Lesion counts · Moderate and severe acne vulgaris

1 finding from 1 review

Light therapies for acne 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 266 participants
Very low

ALA‐PDT vs blue light only

Investigator‐assessed percentage change in ILs Lesion counts · Moderate and severe acne vulgaris

1 finding from 1 review

Light therapies for acne 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 266 participants
Very low

ALA‐PDT vs blue light only

Investigator‐assessed severe adverse effects Application site blister · Moderate and severe acne vulgaris

1 finding from 1 review

Light therapies for acne 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 266 participants
Very low

ALA‐PDT vs blue light only

Investigator's global assessment (IGA) of improvement Treatment 'success' as defined by IGA score decrease5 · Moderate and severe acne vulgaris

ALA‐PDT showed no clear difference in investigator's global assessment (IGA) of improvement Treatment… compared with blue light only (low certainty).

1 finding from 1 review

Light therapies for acne 2016 · Cochrane Headline outcomes only
RR 0.81 [0.51, 1.29]
1 study · 266 participants
Low